Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001787674 | SCV002031195 | uncertain significance | not provided | 2022-08-25 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533) |
Fulgent Genetics, |
RCV002478022 | SCV002780064 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 5 | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003407809 | SCV004115606 | uncertain significance | GSDME-related disorder | 2023-02-08 | criteria provided, single submitter | clinical testing | The GSDME c.314dupG variant is predicted to result in a frameshift and premature protein termination (p.Ser106Glnfs*48). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.049% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-24784270-G-GC). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Labcorp Genetics |
RCV001787674 | SCV005715470 | likely benign | not provided | 2024-11-16 | criteria provided, single submitter | clinical testing |